🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT07501299
Recruiting Observational

HeartBeam ECG Registry

NCT07501299 · tracked via the Priya Life Science USA tracker
Sponsor
HeartBeam, Inc.
Phase
Observational
Started
2026-03-30
Last updated
2026-07-20

Condition(s) studied

Atrial FibrillationAtrial FlutterBradycardiaTachycardiaArrhythmia

Investigational drug(s) / intervention(s)

Electrocardiogram (ECG)

Electrocardiogram (ECG): The intervention consists of non-invasive ECG recordings obtained using the HeartBeam System. Participants will use the device to capture cardiac electrical activity for assessment of heart rhythm, conduction patterns, and heart rate abnormalities in a clinical setting.

Study summary

The HeartBeam ECG Registry will collect ECG recordings acquired with the HeartBeam System with relevant clinical information in clinical settings.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
Accepted
Inclusion Criteria: 1. Undergoing ECG as part of standard of care. 2. Able and willing to provide written informed consent. Exclusion Criteria: 1. Open chest wounds or surgery to the chest or abdomen within 30 days. 2. Inability to complete ECG acquisition with either HeartBeam device or standard 12-L ECG. 3. Unstable condition where registry participation may interfere with care.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Allegheny Health Network Pittsburgh Pennsylvania Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07501299 on ClinicalTrials.gov ↗ ← All trials in the USA